Virtual Medicinal Product (VMP) - Generic Comirnaty COVID-19 mRNA Vaccine 30micrograms/0.3ml dose concentrate for dispersion for injection multidose vials

Navigation

Name Details

Name Start Date End Date
Name Current Name Generic Comirnaty COVID-19 mRNA Vaccine 30micrograms/0.3ml dose concentrate for dispersion for injection multidose vials Start Date 08-09-2021 End Date
Previous Name Previous Name Generic COVID-19 mRNA Vaccine Pfizer-BioNTech BNT162b2 30micrograms/0.3ml dose concentrate for dispersion for injection multidose vials Start Date 01-09-2021 End Date 07-09-2021

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
0.3
UDFS UOM
ml
Unit Dose UOM
dose

Summary

Prescribing Status
Never Valid To Prescribe As A VMP
Controlled Drug Category
No Controlled Drug Status
Route
Intramuscular
Form
Dispersion for injection
Ontology Form/Route
dispersioninjection.intramuscular
Non-availability Indicator
Actual Products not Available
Name Basis
Other

Codes

ATC Code
n/a
BNF Start Date End Date
Current BNF 14040000 Start Date 04-04-2022 End Date
Previous BNF 14040000 Start Date 22-10-2020 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
39116111000001100 22-10-2020

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Tozinameran Based on Ingredient Substance 100 microgram 1 ml

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
6 dose
1170 dose